Status:
NOT_YET_RECRUITING
A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
University of Bordeaux
Conditions:
Glioblastoma
Eligibility:
All Genders
18+ years
Brief Summary
BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor sample...
Detailed Description
Glioblastoma is the most common and aggressive primary brain tumor in adults, whose relapse is almost systematic despite surgery, radiation therapy and temozolomide (STUPP protocol). Several clinical ...
Eligibility Criteria
Inclusion
- Patients of 18 years or older, with highly suspected glioblastoma on neuro-imagery
- Planned surgical tumor resection,
- No objection to participate in research
- Signed genetic consent
Exclusion
- Patients under guardianship, curatorship or protective supervision
- Taking immunosuppressants
- Pregnant or breast-feeding women
- Patients deprived of their liberty by judicial or administrative decision, or under psychiatric care
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT07173829
Start Date
September 1 2025
End Date
December 1 2030
Last Update
September 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.